Cargando…
Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up()
BACKGROUND: Recently, attention has been focused on mesenchymal stem cells (MSC) because of their unique ability to suppress inflammation induced by cytokine storms caused by COVID-19. Several patients have been successfully treated in this manner. After one year of treatment with Wharton's jel...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635897/ https://www.ncbi.nlm.nih.gov/pubmed/36373143 http://dx.doi.org/10.1016/j.genrep.2022.101691 |